Skip to main content
Top
Published in: Clinical Rheumatology 2/2010

01-02-2010 | Case Report

Systemic sclerosis sine scleroderma and calcinosis cutis: report of a rare case

Authors: Nand Lal Sharma, Vikram K. Mahajan, Nitin Ranjan, Vikas Chander Sharma, Mudita Gupta

Published in: Clinical Rheumatology | Issue 2/2010

Login to get access

Abstract

Systemic sclerosis sine scleroderma is a rare form of limited cutaneous scleroderma. These patients manifest without cutaneous involvement, but do not differ in its clinical or laboratory features and prognosis from classical systemic sclerosis. In the absence of cutaneous signs/symptoms, its diagnosis is delayed leading to morbidity. The exact prevalence of dystrophic calcification in systemic sclerosis sine scleroderma, though a feature of systemic sclerosis, is not known. Development of dystrophic calcification further aggravates patient's woes. This paper describes systemic sclerosis sine scleroderma in a 17-year-old girl diagnosed initially as seronegative juvenile rheumatoid arthritis. She developed progressively increasing disk-like masses of calcinosis over the gluteal regions, knee, elbow, and ankle joints fixed to the overlying skin associated with malaise, anorexia, and weight loss. There was no Raynaud's phenomenon, dysphagia, dyspnoea, sclerodermatous skin, sclerodactyly, telangectasias, or muscle tenderness/weakness. Digital pitted scars, elevated anticentromere antibody values, esophageal hypomotility, and fluffy calcification in subdermal soft tissues in gluteal regions and around wrist, hip, knees, heels, and ankle joints (without affecting the underlying structures) were detected. Therapy with diltiazem and magnesium/aluminum antacids was useful in resolving calcinosis.
Literature
1.
go back to reference Zwettler U, Andrassy K, Waldherr R, Ritz E (1993) Scleroderma renal crisis as a presenting feature in the absence of skin involvement. Am J Kidney Dis 22:53–56PubMed Zwettler U, Andrassy K, Waldherr R, Ritz E (1993) Scleroderma renal crisis as a presenting feature in the absence of skin involvement. Am J Kidney Dis 22:53–56PubMed
2.
go back to reference Poormoghim H, Lucas M, Fertig N, Medsger TA Jr (2000) Systemic sclerosis sine scleroderma: demographic, clinical and serologic features and survival in forty eight patients. Artheritis Rheum 43:444–451CrossRef Poormoghim H, Lucas M, Fertig N, Medsger TA Jr (2000) Systemic sclerosis sine scleroderma: demographic, clinical and serologic features and survival in forty eight patients. Artheritis Rheum 43:444–451CrossRef
3.
go back to reference Abrams HL, Carnes WH, Eaton J (1954) Alimentary tract in disseminated scleroderma with emphasis on small bowel. Arch Intern Med 94:61–81 Abrams HL, Carnes WH, Eaton J (1954) Alimentary tract in disseminated scleroderma with emphasis on small bowel. Arch Intern Med 94:61–81
5.
go back to reference Subcommittee for Scleroderma Criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee (1980) Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum 23:581–588CrossRef Subcommittee for Scleroderma Criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee (1980) Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum 23:581–588CrossRef
6.
go back to reference Medsger TA Jr (1985) Comment on scleroderma criteria cooperative study. In: Black CM, Myers AR (eds) Current topics in rheumatology, systemic sclerosis (scleroderma). Gower Medical Puublishing, New York, pp 16–17 Medsger TA Jr (1985) Comment on scleroderma criteria cooperative study. In: Black CM, Myers AR (eds) Current topics in rheumatology, systemic sclerosis (scleroderma). Gower Medical Puublishing, New York, pp 16–17
7.
8.
9.
go back to reference Goodfield MJD, Jones SK, Veale DJ (2004) Connective tissue diseases: calcinosis. In: Burns T, Breathnach S, Coxn GC (eds) Textbook of dermatology, 7th edn. Blackwell Science, Oxford, pp 56–102 Goodfield MJD, Jones SK, Veale DJ (2004) Connective tissue diseases: calcinosis. In: Burns T, Breathnach S, Coxn GC (eds) Textbook of dermatology, 7th edn. Blackwell Science, Oxford, pp 56–102
10.
go back to reference Kawakami T, Nakamura C, Hasegawa H, Eda S, Akahane S, Yamazaki T et al (1986) Ultrastructural study of calcinosis universalis with dermatomyositis. J Cutan Pathol 13:135–143CrossRefPubMed Kawakami T, Nakamura C, Hasegawa H, Eda S, Akahane S, Yamazaki T et al (1986) Ultrastructural study of calcinosis universalis with dermatomyositis. J Cutan Pathol 13:135–143CrossRefPubMed
11.
go back to reference Shoemaker LR (1999) Expanding role of biphosphonate therapy in children. Pediatr 134:264–267CrossRef Shoemaker LR (1999) Expanding role of biphosphonate therapy in children. Pediatr 134:264–267CrossRef
12.
go back to reference Nakagawa T, Takaiwa T (1993) Calcinosis cutis in juvenile dermatomyositis responsive to aluminum hydroxide treatment. J Dermatol 20:558–560PubMed Nakagawa T, Takaiwa T (1993) Calcinosis cutis in juvenile dermatomyositis responsive to aluminum hydroxide treatment. J Dermatol 20:558–560PubMed
13.
go back to reference Cukierman T, Elinav E, Korem M, Chajek-Shaul T (2004) Low dose warfarin treatment for calcinosis in patient with systemic sclerosis. Ann Rheum Dis 63:1341–1343CrossRefPubMed Cukierman T, Elinav E, Korem M, Chajek-Shaul T (2004) Low dose warfarin treatment for calcinosis in patient with systemic sclerosis. Ann Rheum Dis 63:1341–1343CrossRefPubMed
14.
go back to reference Palmieri GM, Sebes JI, Aelion JA, Moinuddin JA, Ray MW, Wood GC et al (1995) Treatment of calcinosis with diltiazem. Arthritis Rheum 38:1646–1654CrossRefPubMed Palmieri GM, Sebes JI, Aelion JA, Moinuddin JA, Ray MW, Wood GC et al (1995) Treatment of calcinosis with diltiazem. Arthritis Rheum 38:1646–1654CrossRefPubMed
15.
go back to reference Steid L, Ditmar R (1990) Treatment of soft tissue calcification with local and oral magnesium therapy. Magnes Res 3:113–119 Steid L, Ditmar R (1990) Treatment of soft tissue calcification with local and oral magnesium therapy. Magnes Res 3:113–119
Metadata
Title
Systemic sclerosis sine scleroderma and calcinosis cutis: report of a rare case
Authors
Nand Lal Sharma
Vikram K. Mahajan
Nitin Ranjan
Vikas Chander Sharma
Mudita Gupta
Publication date
01-02-2010
Publisher
Springer-Verlag
Published in
Clinical Rheumatology / Issue 2/2010
Print ISSN: 0770-3198
Electronic ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-009-1303-z

Other articles of this Issue 2/2010

Clinical Rheumatology 2/2010 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.